Aims Of patients with atrial fibrillation (AF), approximately 10% undergo percutaneous
coronary intervention (PCI). We studied the safety and efficacy of dual vs. triple …

Importance Atrial fibrillation (AF) is the most common cardiac arrhythmia and is associated
with a 5-fold increase in the risk for stroke. Type 2 diabetes is an independent risk factor for …

Objectives To study patient selection for and persistence with ADP receptor-inhibiting oral
antiplatelet (OAP) treatment after acute coronary syndrome (ACS). Design Observational …

Background: Data regarding the clinical outcomes in patients with atrial fibrillation (AF)
receiving dual antiplatelet therapy (DAPT) and an anticoagulant in addition to DAPT (DAPT+ …

Backgrounds: Previous studies have demonstrated that drug-eluting stents (DESs) are more
effective than bare metal stents (BMSs) in reducing the risk of myocardial infarction in the …

Warfarin is an alternate choice for patients who are not eligible for non-vitamin K oral
anticoagulants after acute myocardial infarction (AMI). This study aimed to compare the long …

Introduction: Balancing the risk of recurrent ischemia and bleeding among patients with non-
valvular atrial fibrillation who undergo percutaneous coronary intervention (PCI) is …

Objectives We aimed to assess the impact of omitting aspirin on clinical outcomes in a real‐
world collective of patients receiving oral anticoagulation (OAC) therapy who were treated …

Stroke prevention is the main priority in the management cascade of atrial fibrillation. Most
patients require long-term oral anticoagulation (OAC) and may require percutaneous …

Background Real‐world effectiveness and safety of antithrombotics in nonvalvular atrial
fibrillation (NVAF) patients in Singapore has not been thoroughly studied. Hypothesis. Users …